|
HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland)
(»add to infobox)
| PERSONS (32/32) |
|
Lauri AALTONEN (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Kari ALITALO (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Carl-Henrik BONSDORFF VON (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Eero CASTRÉN (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Akseli HEMMINKI (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Jouni HIRVONEN (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Harry HOLTHÖFER (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Elina IKONEN (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Olli JÄNNE (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Sakari KNUUTILA (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Timo KORHONEN (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Anna-Elina LEHESJOKI (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Tomi MÄKELÄ (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Päivi OJALA (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Timo OTONKOSKI (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Jorma PAAVONEN (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Aarno PALOTIE (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Ulla PIRVOLA (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Tarja PORKKA-HEISKANEN (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Mart SAARMA (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Petri SALVEN (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Jim SCHRÖDER (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Ulf-Hakan STENMAN (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Jussi TAIPALE (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Jaakko TUOMILEHTO (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Raimo TUOMINEN (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Timo TUURI (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Jaana TYYNELÄ-VESTERINEN (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Esko UKKONEN (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Arto URTTI (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Kristian WAHLBECK (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
Carina WALLGREN-PETTERSSON (Contact / HELSINGIN YLIOPISTO (FI181 - Uusimaa) (FI - Finland))
| RELATED THEMATIC AREAS (21/21) |
|
Across the area
Bioinformatics
Combating cardiovascular diseases, diabetes, and rare diseases
Development and testing of new preventive and therapeutic tools
Development of new diagnostics
Development of new in vitro tests to replace animal experimentation
European human embryonic stem cell registry
Health determinants and the provision of high quality and sustainable health care services and pension systems
Innovative research in post-genomics
Modulation of apoptosis in cancer prevention and therapy
Multidisciplinary functional genomics approaches
Prevention, detection and treatment of familial cancers, such as cancer of the prostate, ovary, breast, colon and skin
Public health issues
Rational and accelerated development of new, safer, more effective drugs
Realising ERA objectives
Research on tumours associated with infectious agents
Small-ligand libraries: improved tools for exploration and prospective anti-tumor therapy
Studying human development and the ageing process
Studying the brain and combating diseases of the nervous system
Translational research on promising predictive and prognostic markers
Tumour-host interactions
| RELATED PROJECTS (42/42) |
|
INTERACT - An examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes (Life sciences, genomics and biotechnology for health)
BIOSAPIENS - A European Network for Integrated Genome Annotation (Life sciences, genomics and biotechnology for health)
REGULATORY GENOMICS - Advanced genomics instruments, technology and methods for determination of transcription factor binding specificities; applications for identification of genes predisposing to colorectal cancer (Life sciences, genomics and biotechnology for health)
EUROHEAR - Advances in hearing science : from functional genomics to therapies (Life sciences, genomics and biotechnology for health)
POLEXGENE - Biocompatible non-viral polymeric gene delivery systems for the ex vivo treatment of ocular and cardiovascular diseases with high unmet medical need (Life sciences, genomics and biotechnology for health)
APOTHERAPY - CD40 ligand-based modalities for the treatment of solid tumours. (Life sciences, genomics and biotechnology for health)
CRESCENDO - Consortium for Research into Nuclear Receptors in Development and Aging (Life sciences, genomics and biotechnology for health)
EPIGENCHLAMYDIA - Contribution of molecular epidemiology and host-pathogen genomics to understand Chlamydial trachomatis disease (Life sciences, genomics and biotechnology for health)
TONECA - Coordination Action on the Aetiology, pathology and prediction of type 1 diabetes in Europe (Life sciences, genomics and biotechnology for health)
TCAC IN CANCER - DEFECTS IN THE TRICARBOXYLIC ACID (KREBS) CYCLE GENES IN TUMORIGENESIS (Life sciences, genomics and biotechnology for health)
DATAPREV - Developing the evidence base for Mental Health Promotion and Prevention in Europe: a Database of programmes and the production of guidelines for policy and practice (Policy-orientated research)
MEMORIES - Development, characterisation and validation of new and original models for Alzheimer's Disease' (Life sciences, genomics and biotechnology for health)
ENOUGH SLEEP - Disorders of sleep regulation: basic mechanisms and thepapeutic perspectives (Life sciences, genomics and biotechnology for health)
NCL-MODELS - Dissecting neuronal degeneration: Neuronal ceroid lipofuscinoses from genes to function (Life sciences, genomics and biotechnology for health)
ENFIN - ENFIN - an Experimental Network for Functional INtegration (Life sciences, genomics and biotechnology for health)
EU HESC REGISTRY - European human embryonic stem cell registry (Life sciences, genomics and biotechnology for health)
ELIFE - European Lipidomics Initiative (Life sciences, genomics and biotechnology for health)
EUROBONET - European network to promote research into uncommon cancers in adults and children: Pathology, Biology and Genetics of Bone Tumors (Life sciences, genomics and biotechnology for health)
EPG - European Virtual Institute for Functional Genomics of Bacterial Pathogens (Life sciences, genomics and biotechnology for health)
NET2DRUG - From gene regulatory networks to drug prediction. (Life sciences, genomics and biotechnology for health)
EPICURE - Functional Genomics and Neurobiology of Epilepsy: a basis for new therapeutic strategies (Life sciences, genomics and biotechnology for health)
EUROCLOT - Genetic regulation of the end-stage clotting process that leads to thrombotic stroke (Life sciences, genomics and biotechnology for health)
TUMOR-HOST GENOMICS - Genome-wide analysis of signaling pathways in regulation of the interactions between tumor and host cells: Applications for cancer therapy (Life sciences, genomics and biotechnology for health)
CANCERGRID - Grid aided computer system for rapid anti-cancer drug design (Life sciences, genomics and biotechnology for health)
INGENIOUS HYPERCARE - Integrated Genomics, Clinical Research and Care in Hypertension (Life sciences, genomics and biotechnology for health)
LYMPHANGIOGENOMICS - LYMPHANGIOGENOMICS: Genome-Wide Discovery and Functional Analysis of Novel Genes in Lymphangiogenesis (Life sciences, genomics and biotechnology for health)
EUROHEAD - Migraine genes and neurobiological pathways (Life sciences, genomics and biotechnology for health)
SAVEBETA - Molecular pathways underlying decreased beta cell mass in diabetes mellitus (Life sciences, genomics and biotechnology for health)
LINTOP - Optimisation of liver and intestine in vitro model for pharmacokinetics and pharmacodynamics studies (Life sciences, genomics and biotechnology for health)
THERADPOX - Optimised and novel oncolytic adenoviruses and pox viruses in the treatment of cancer: Virotherapy combined with molecular chemotherapy (Life sciences, genomics and biotechnology for health)
ADDNET - Paradigm shift from kidney biopsies to advanced molecular diagnostics from patient urine (Life sciences, genomics and biotechnology for health)
ESTOOLS - Platforms for biomedical discovery with human ES cells (Life sciences, genomics and biotechnology for health)
DIANA - Predictive diagnostics for diabetic nephropathy (DiaNa) - Novel nanotechnology based test platforms (Life sciences, genomics and biotechnology for health)
MMR-RELATED CANCER - Prevention, diagnosis and molecular characterisation of mismatch repair defect-related hereditary cancers of the digestive system (Life sciences, genomics and biotechnology for health)
PROTHETS - PROgnosis and THerapeutic targets in the "Ewing" family of TumourS (Life sciences, genomics and biotechnology for health)
PRO-KINASERESESRCH - Protein kinases - Novel Drug Targets of Post Genomic Era (Life sciences, genomics and biotechnology for health)
EVENT - Providing tools to prevent emergence of enteric viruses (Policy-orientated research)
SAFE - Special Non-Invasive Advances in Foetal and Neonatal Evaluation Network (Life sciences, genomics and biotechnology for health)
EUROPEAN LEUKEMIANET - Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, MDS, CLL, adult ALL) by cooperation and integration of the leading national leukemia netw# (Life sciences, genomics and biotechnology for health)
INCA - The role of chronic INfections in the development of CAncer (Life sciences, genomics and biotechnology for health)
TREAT-NMD - Translational Research in Europe - Assessment and Treatment of Neuromuscular Diseases (Life sciences, genomics and biotechnology for health)
P-MARK - Validation of recently developed diagnostic and prognostic markers and identification of novel markers for prostate cancer using European databases (Life sciences, genomics and biotechnology for health)
|
|
|
LifeCompetence operated by AVEDAS
Contact: support@avedas.com
|
